Annual SG&A
$72.89 M
+$11.22 M+18.19%
31 December 2023
Summary:
LeMaitre Vascular annual selling, general & administrative expenses is currently $72.89 million, with the most recent change of +$11.22 million (+18.19%) on 31 December 2023. During the last 3 years, it has risen by +$26.68 million (+57.76%). LMAT annual SG&A is now at all-time high.LMAT Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$20.37 M
+$570.00 K+2.88%
30 September 2024
Summary:
LeMaitre Vascular quarterly selling, general & administrative expenses is currently $20.37 million, with the most recent change of +$570.00 thousand (+2.88%) on 30 September 2024. Over the past year, it has increased by +$2.96 million (+17.02%). LMAT quarterly SG&A is now -1.57% below its all-time high of $20.70 million, reached on 31 March 2024.LMAT Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
$504.63 M
+$27.43 M+5.75%
30 September 2024
Summary:
LeMaitre Vascular TTM selling, general & administrative expenses is currently $504.63 million, with the most recent change of +$27.43 million (+5.75%) on 30 September 2024. Over the past year, it has increased by +$434.91 million (+623.88%). LMAT TTM SG&A is now at all-time high.LMAT TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LMAT Selling, General & Administrative Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +18.2% | +17.0% | +623.9% |
3 y3 years | +57.8% | +57.4% | +890.5% |
5 y5 years | +61.9% | +70.1% | +947.2% |
LMAT Selling, General & Administrative Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +57.8% | -1.6% | +57.4% | at high | +63.1% |
5 y | 5 years | at high | +61.9% | -1.6% | +103.4% | at high | +154.6% |
alltime | all time | at high | +921.2% | -1.6% | +305.7% | at high | +842.9% |
LeMaitre Vascular Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $20.37 M(+2.9%) | $79.58 M(+3.9%) |
June 2024 | - | $19.80 M(-4.3%) | $76.62 M(+2.5%) |
Mar 2024 | - | $20.70 M(+10.6%) | $74.76 M(+2.6%) |
Dec 2023 | $72.89 M(+18.2%) | $18.71 M(+7.4%) | $72.89 M(+4.6%) |
Sept 2023 | - | $17.41 M(-2.9%) | $69.71 M(+2.9%) |
June 2023 | - | $17.94 M(-4.7%) | $67.76 M(+3.6%) |
Mar 2023 | - | $18.83 M(+21.2%) | $65.39 M(+6.0%) |
Dec 2022 | $61.67 M(+16.0%) | $15.53 M(+0.5%) | $61.67 M(+2.2%) |
Sept 2022 | - | $15.46 M(-0.7%) | $60.33 M(+4.3%) |
June 2022 | - | $15.57 M(+3.1%) | $57.82 M(+4.7%) |
Mar 2022 | - | $15.10 M(+6.4%) | $55.25 M(+3.9%) |
Dec 2021 | $53.16 M(+15.1%) | $14.20 M(+9.7%) | $53.16 M(+4.3%) |
Sept 2021 | - | $12.95 M(-0.4%) | $50.95 M(+3.8%) |
June 2021 | - | $13.00 M(-0.1%) | $49.06 M(+6.5%) |
Mar 2021 | - | $13.01 M(+8.5%) | $46.07 M(-0.3%) |
Dec 2020 | $46.20 M(-6.5%) | $11.99 M(+8.4%) | $46.20 M(-1.1%) |
Sept 2020 | - | $11.06 M(+10.4%) | $46.69 M(-1.9%) |
June 2020 | - | $10.02 M(-23.7%) | $47.62 M(-4.3%) |
Mar 2020 | - | $13.14 M(+5.2%) | $49.74 M(+0.7%) |
Dec 2019 | $49.39 M(+9.7%) | $12.48 M(+4.2%) | $49.39 M(+2.5%) |
Sept 2019 | - | $11.98 M(-1.4%) | $48.19 M(+2.9%) |
June 2019 | - | $12.14 M(-5.0%) | $46.81 M(+1.7%) |
Mar 2019 | - | $12.79 M(+13.4%) | $46.01 M(+2.2%) |
Dec 2018 | $45.01 M(+4.8%) | $11.28 M(+6.3%) | $45.01 M(+2.1%) |
Sept 2018 | - | $10.61 M(-6.5%) | $44.08 M(-0.4%) |
June 2018 | - | $11.34 M(-3.8%) | $44.24 M(+2.3%) |
Mar 2018 | - | $11.79 M(+13.9%) | $43.24 M(+0.7%) |
Dec 2017 | $42.96 M(+6.2%) | $10.35 M(-3.9%) | $42.96 M(-1.0%) |
Sept 2017 | - | $10.76 M(+4.0%) | $43.37 M(+1.5%) |
June 2017 | - | $10.35 M(-10.1%) | $42.75 M(+0.9%) |
Mar 2017 | - | $11.50 M(+6.9%) | $42.35 M(+4.7%) |
Dec 2016 | $40.46 M(+10.0%) | $10.76 M(+6.2%) | $40.46 M(+3.1%) |
Sept 2016 | - | $10.14 M(+1.9%) | $39.24 M(+3.1%) |
June 2016 | - | $9.95 M(+3.5%) | $38.05 M(+3.1%) |
Mar 2016 | - | $9.61 M(+0.6%) | $36.92 M(+0.4%) |
Dec 2015 | $36.79 M(+2.3%) | $9.55 M(+6.8%) | $36.79 M(+2.2%) |
Sept 2015 | - | $8.94 M(+1.4%) | $35.98 M(+0.2%) |
June 2015 | - | $8.82 M(-6.9%) | $35.90 M(-0.0%) |
Mar 2015 | - | $9.47 M(+8.4%) | $35.91 M(-0.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2014 | $35.98 M(+3.6%) | $8.74 M(-1.3%) | $35.98 M(-1.3%) |
Sept 2014 | - | $8.86 M(+0.3%) | $36.44 M(+1.0%) |
June 2014 | - | $8.83 M(-7.4%) | $36.07 M(+1.3%) |
Mar 2014 | - | $9.54 M(+3.6%) | $35.61 M(+2.6%) |
Dec 2013 | $34.72 M(+9.2%) | $9.21 M(+8.5%) | $34.72 M(+3.0%) |
Sept 2013 | - | $8.49 M(+1.4%) | $33.71 M(+2.1%) |
June 2013 | - | $8.37 M(-3.2%) | $33.02 M(+1.4%) |
Mar 2013 | - | $8.65 M(+5.5%) | $32.55 M(+2.4%) |
Dec 2012 | $31.78 M(+3.9%) | $8.20 M(+5.0%) | $31.78 M(+2.4%) |
Sept 2012 | - | $7.80 M(-1.3%) | $31.03 M(+0.8%) |
June 2012 | - | $7.90 M(+0.3%) | $30.78 M(+0.4%) |
Mar 2012 | - | $7.88 M(+5.9%) | $30.66 M(+0.2%) |
Dec 2011 | $30.60 M(+2.3%) | $7.44 M(-1.6%) | $30.60 M(-1.6%) |
Sept 2011 | - | $7.56 M(-2.9%) | $31.10 M(+1.1%) |
June 2011 | - | $7.78 M(-0.5%) | $30.77 M(+1.8%) |
Mar 2011 | - | $7.82 M(-1.4%) | $30.23 M(+1.0%) |
Dec 2010 | $29.91 M(+8.5%) | $7.93 M(+9.7%) | $29.91 M(+2.4%) |
Sept 2010 | - | $7.23 M(-0.2%) | $29.21 M(+0.8%) |
June 2010 | - | $7.24 M(-3.5%) | $28.98 M(+2.0%) |
Mar 2010 | - | $7.51 M(+3.9%) | $28.40 M(+3.0%) |
Dec 2009 | $27.56 M(-7.4%) | $7.23 M(+3.2%) | $27.56 M(+2.0%) |
Sept 2009 | - | $7.00 M(+5.1%) | $27.02 M(+1.8%) |
June 2009 | - | $6.66 M(-0.1%) | $26.55 M(-4.4%) |
Mar 2009 | - | $6.67 M(-0.2%) | $27.78 M(-6.7%) |
Dec 2008 | $29.76 M(+2.7%) | $6.68 M(+2.2%) | $29.76 M(-4.0%) |
Sept 2008 | - | $6.54 M(-17.1%) | $31.01 M(-1.2%) |
June 2008 | - | $7.89 M(-8.9%) | $31.40 M(+3.1%) |
Mar 2008 | - | $8.66 M(+9.2%) | $30.45 M(+5.1%) |
Dec 2007 | $28.98 M(+30.0%) | $7.93 M(+14.5%) | $28.98 M(+4.8%) |
Sept 2007 | - | $6.92 M(-0.3%) | $27.65 M(+7.1%) |
June 2007 | - | $6.94 M(-3.3%) | $25.81 M(+5.5%) |
Mar 2007 | - | $7.18 M(+8.8%) | $24.48 M(+9.7%) |
Dec 2006 | $22.29 M(+28.4%) | $6.60 M(+29.6%) | $22.32 M(+42.0%) |
Sept 2006 | - | $5.09 M(-9.2%) | $15.72 M(+47.9%) |
June 2006 | - | $5.61 M(+11.6%) | $10.63 M(+111.6%) |
Mar 2006 | - | $5.02 M | $5.02 M |
Dec 2005 | $17.36 M(+18.2%) | - | - |
Dec 2004 | $14.69 M(+60.5%) | - | - |
Dec 2002 | $9.16 M(+28.3%) | - | - |
Dec 2001 | $7.14 M | - | - |
FAQ
- What is LeMaitre Vascular annual selling, general & administrative expenses?
- What is the all time high annual SG&A for LeMaitre Vascular?
- What is LeMaitre Vascular annual SG&A year-on-year change?
- What is LeMaitre Vascular quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for LeMaitre Vascular?
- What is LeMaitre Vascular quarterly SG&A year-on-year change?
- What is LeMaitre Vascular TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for LeMaitre Vascular?
- What is LeMaitre Vascular TTM SG&A year-on-year change?
What is LeMaitre Vascular annual selling, general & administrative expenses?
The current annual SG&A of LMAT is $72.89 M
What is the all time high annual SG&A for LeMaitre Vascular?
LeMaitre Vascular all-time high annual selling, general & administrative expenses is $72.89 M
What is LeMaitre Vascular annual SG&A year-on-year change?
Over the past year, LMAT annual selling, general & administrative expenses has changed by +$11.22 M (+18.19%)
What is LeMaitre Vascular quarterly selling, general & administrative expenses?
The current quarterly SG&A of LMAT is $20.37 M
What is the all time high quarterly SG&A for LeMaitre Vascular?
LeMaitre Vascular all-time high quarterly selling, general & administrative expenses is $20.70 M
What is LeMaitre Vascular quarterly SG&A year-on-year change?
Over the past year, LMAT quarterly selling, general & administrative expenses has changed by +$2.96 M (+17.02%)
What is LeMaitre Vascular TTM selling, general & administrative expenses?
The current TTM SG&A of LMAT is $504.63 M
What is the all time high TTM SG&A for LeMaitre Vascular?
LeMaitre Vascular all-time high TTM selling, general & administrative expenses is $79.58 M
What is LeMaitre Vascular TTM SG&A year-on-year change?
Over the past year, LMAT TTM selling, general & administrative expenses has changed by +$434.91 M (+623.88%)